In the GLP-1 weight loss market, it's largely been a two-horse race between Eli Lilly and Novo Nordisk (NYSE: NVO). The two ...

Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...

One developer of a weight loss medication, clinical-stage biotech Structure Therapeutics ( GPCR 0.16%), was a victim of a ...

Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Sudair Pharma aims to localise insulin production, contributing to the continuity of supply and reducing reliance on imports ...

EU exports to the US reached $605.8 billion in 2024, according to the US Census Bureau. Pharmaceutical companies are ...

The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Kilitch Drugs(I) Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 511.90 Crore) operating in Pharmaceuticals sector. Kilitch Drugs(I) Ltd. key Products/Revenue ...

Aarti Drugs Ltd. key Products/Revenue Segments include Pharmaceuticals, Scrap and Export Incentives for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the company has reported a ...